Company intelligence / Profile preview

Grupo Vita

Mexico City, Ciudad de México, Mexico

Ownership: Private
Development stage: Other

Overview

Grupo Vita is a Mexican pharmaceutical company dedicated to the development, manufacturing, and commercialization of a wide range of healthcare products. The company specializes in generic and branded generic medications across various therapeutic areas, including antibiotics, analgesics, and gastrointestinal treatments. Grupo Vita operates modern manufacturing facilities in Mexico and maintains a significant distribution network to serve the national market. Its portfolio includes both prescription drugs and over-the-counter (OTC) products, focusing on providing affordable and high-quality therapeutic options for common and chronic conditions.

Therapeutic areas: NeurologyInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Grupo Vita.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grupo Vita.

Explore the full profile